Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges

Page view(s)
26
Checked on Mar 25, 2024
Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges
Title:
Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges
Journal Title:
Biotechnology Advances
Publication Date:
29 September 2018
Citation:
Lee E, Sivalingam J, Lim ZR, et al. Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges. Biotechnol Adv. 2018;36(8):2118–2128. doi:10.1016/j.biotechadv.2018.09.006
Abstract:
In vitro generation of red blood cells (RBCs) has the potential to circumvent the shortfalls in global demand for blood for transfusion applications. The conventional approach for RBC generation has been from differentiation of hematopoietic stem cells (HSCs) derived from cord blood, adult bone marrow or peripheral blood. More recently, RBCs have been generated from human induced pluripotent stem cells (hiPSCs) as well as from immortalized adult erythroid progenitors. In this review, we highlight the recent advances to RBC generation from these different approaches and discuss the challenges and new strategies that can potentially make large-scale in vitro generation of RBCs a feasible approach.
License type:
PublisherCopyrights
Funding Info:
This work was supported by a Joint Council Office DP grant from Agency for Science, Technology and Research, Singapore (1331AFG075).
Description:
ISSN:
0734-9750
1873-1899
Files uploaded: